Medical device recalls Moderate risk

Horiba Instruments Incorporated recalls Clinical Chemistry, ABX Pentra Lipase CP, ABX Pentra 400/Pentrac400, REF: A11A01631, Model/Part # 1220001631, UDI # 036…

Recall date
October 30, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0119-2020
FDA classification
Class II
Brand / firm
Horiba Instruments Incorporated
Sold / distributed
US: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY

Why it was recalled

Potential for chemical analyzer to report abnormal results due to an interference with triglycerides CP and Cholesterol CP. An over estimation of the lipase concentration could be observed and a patient result could be declared abnormal by the instrument due to these interferences instead of normal result < 38 U/L (or < reference value used in your laboratory).

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Clinical Chemistry, ABX Pentra Lipase CP, ABX Pentra 400/Pentrac400, REF: A11A01631, Model/Part # 1220001631, UDI # 03610230004944

Get recall alerts

Free email alert whenever Horiba Instruments Incorporated has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Horiba Instruments Incorporated